5 Fast Facts About Retail Clinics from Kalorama Information’s Latest Report

/by Bruce Carlson

Retail clinics, small clinics usually staffed by a nurse practitioner or physician assistant, offer competitive hours and convenience to clients, and a great bonus for retailers. But how are they faring? Kalorama’s report “Retail Clinics 2019 Forecast: Locations, Revenues, Supplier Sales, Trends, Consumer Survey” notes the following:  They’re Growing Locations and Revenues: By the end […]

Read more

Artificial Intelligence, One Day, Could Keep The Doctor Away

/by Bruce Carlson

You wake up with an angry stomach, but this time it’s got nothing to do with that questionable leftover poké dish you’d kept in the fridge for a week. No, there’s more to this, but is it enough to put everything on hold to call a doctor and potentially wait all day, missing work, just […]

Read more

Smartphones and IVD: Early, But Getting There

/by Bruce Carlson

The current developments, product launches and company plans in IVD testing on smartphone platforms has been detailed by Kalorama Information in a recent report by Kalorama’s Rob Camp: https://www.kaloramainformation.com/Smartphone-Based-IVD-Products-Trends-Potential-12019398/ We summarize some of the findings of our study here.  This represents a fraction of the findings of the report: The techniques that can most successfully harness […]

Read more

CVS-Aetna Merger and Walgreens-LabCorp Partnership: Assessing The Impact

/by Bruce Carlson

In separate moves, the two largest pharmacy retailers dramatically changed their businesses. CVS merged with healthcare insurance giant Aetna. But Walgreens also had news – the drugstore giant merged with clinical reference company LabCorp to put an announced 600 consumer testing stations in its retail stores. Both are a good sign for the market for […]

Read more

Moving the Ball Forward on EMR Connectivity for IVD Devices

/by Bruce Carlson

  Authored by Julie Kirkwood, Kalorama Information Correspondent Until surprisingly recently, the connections between laboratory instruments and laboratory computers were based on standards developed in the 1990s. For example, one of the standards, ASTM E1394 (later revised and renamed CLSI LIS2) dates back to 1997, the year before Google was invented, when dial-up modems were still used […]

Read more

PAMA brings huge changes to lab price testing, faces resistance from ACLA

/by Bruce Carlson

We at Kalorama Information have just released the Eleventh Edition of our flagship publication,The Worldwide Market for  In Vitro   Diagnostics. This report has been updated for two decades, keeping readers informed about developments in all areas of the IVD industry, around the world, in one volume. At 1,800 pages, the report provides market size estimates and projections […]

Read more

Next Generation Sequencing Continues to Make Strides: Neonatal Screening, Onco-genomics, Infectious Disease Dx, and More

/by Bruce Carlson

Next-generation sequencing (NGS) in diagnostics is rapidly growing, having made great strides since the conclusion of the Human Genome Project fifteen years ago. Increasingly rapid and effective testing capabilities for hereditary diseases, cancers, cardiac and respiratory conditions, neurodegenerative disorders, and even infectious disease, are either on the horizon or have arrived. The promise of DNA […]

Read more

Kalorama To Present IVD Market Findings at BIOMEDevice

/by Bruce Carlson

In many ways, the IVD market of today does not resemble the market five years ago.  2018 appears to be the year where a number of trends that had been discussed began to gel.  With that in mind, Kalorama Information will be on hand for UBM’s BIOMedDevice Convention in San Jose, CA next month.   In […]

Read more

China’s IVD Market: Attractive Target for Surplus Growth

/by Bruce Carlson

China’s IVD market reached $3,200 million in 2017, in line with growth estimates published by Kalorama and elsewhere, and the fast pace of market growth is expected to continue. Supporting growth will be a modernizing healthcare infrastructure and steady migration from manual to automated processes. This was the conclusion of Kalorama Information’s recent report, IVD in […]

Read more

Four Things to Know About The Monoclonal Antibodies – “mAbs” Market

/by Bruce Carlson

Kalorama Information notes 4 trends in monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells that seek out and destroy harmful foreign substances – topped $100 billion in 2017, according to Kalorama Information What’s Trending in Monoclonal Antibodies, examines the several types of monoclonal antibodies on the market and in development, looking at […]

Read more